Insufficient scRNA-seq data for expression of PLA2G2E at single-cell level.
Insufficient scRNA-seq data for expression of PLA2G2E at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 10% | 0.13 | 65 / 653 | 34% | 1.27 | 208 / 605 |
bladder | 29% | 0.33 | 6 / 21 | 1% | 0.07 | 6 / 504 |
skin | 22% | 9.26 | 405 / 1809 | 0% | 0.01 | 1 / 472 |
intestine | 20% | 0.65 | 190 / 966 | 2% | 0.07 | 10 / 527 |
ovary | 18% | 0.23 | 33 / 180 | 0% | 0.01 | 2 / 430 |
brain | 17% | 0.44 | 436 / 2642 | 0% | 0 | 0 / 705 |
prostate | 13% | 0.16 | 32 / 245 | 1% | 0.04 | 7 / 502 |
kidney | 13% | 0.17 | 12 / 89 | 0% | 0.01 | 2 / 901 |
esophagus | 10% | 0.12 | 146 / 1445 | 3% | 0.42 | 6 / 183 |
lung | 12% | 0.14 | 71 / 578 | 1% | 0.01 | 7 / 1155 |
stomach | 9% | 0.10 | 31 / 359 | 3% | 0.17 | 10 / 286 |
uterus | 11% | 0.16 | 19 / 170 | 1% | 0.02 | 3 / 459 |
adipose | 10% | 0.17 | 121 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 10% | 0.12 | 133 / 1335 | 0% | 0 | 0 / 0 |
liver | 8% | 0.09 | 18 / 226 | 1% | 0.11 | 4 / 406 |
heart | 9% | 0.11 | 75 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 8% | 0.10 | 21 / 258 | 0% | 0.01 | 1 / 230 |
peripheral blood | 8% | 0.09 | 76 / 929 | 0% | 0 | 0 / 0 |
breast | 7% | 0.09 | 34 / 459 | 0% | 0 | 0 / 1118 |
muscle | 7% | 0.09 | 57 / 803 | 0% | 0 | 0 / 0 |
spleen | 6% | 0.07 | 14 / 241 | 0% | 0 | 0 / 0 |
pancreas | 5% | 0.05 | 16 / 328 | 1% | 0.01 | 1 / 178 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0034374 | Biological process | low-density lipoprotein particle remodeling |
GO_0006954 | Biological process | inflammatory response |
GO_0046471 | Biological process | phosphatidylglycerol metabolic process |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0005515 | Molecular function | protein binding |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | PLA2G2E |
Protein name | Group IIE secretory phospholipase A2 (GIIE sPLA2) (sPLA2-IIE) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2E) |
Synonyms | |
Description | FUNCTION: Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids . Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity), releasing various unsaturated fatty acids including oleoate, linoleoate, arachidonate, docosahexaenoate and lysophosphatidylethanolamines in preference to lysophosphatidylcholines . In response to high-fat diet, hydrolyzes minor lipoprotein phospholipids including phosphatidylserines, phosphatidylinositols and phosphatidylglycerols, altering lipoprotein composition and fat storage in adipose tissue and liver (By similarity). May act in an autocrine and paracrine manner . Contributes to lipid remodeling of cellular membranes and generation of lipid mediators involved in pathogen clearance. Cleaves sn-2 fatty acyl chains of phosphatidylglycerols and phosphatidylethanolamines, which are major components of membrane phospholipids in bacteria . Acts as a hair follicle phospholipase A2. Selectively releases lysophosphatidylethanolamines (LPE) and various unsaturated fatty acids in skin to regulate hair follicle homeostasis (By similarity). May regulate the inflammatory response by releasing arachidonate, a precursor of prostaglandins and leukotrienes . Upon allergen exposure, may participate in allergic inflammatory response by enhancing leukotriene C4 synthesis and degranulation in mast cells (By similarity). . |
Accessions | Q9NZK7 ENST00000375116.3 |